FGF23 and chronic kidney disease: In contrast to our data in people with stage 3 CKD and albuminuria with and without diabetes 7-day treatment with empagliflozin resulted in a rise on FGF-23 levels only in people with diabetic CKD, but no effect on albuminuria was observed (34).